Investing in Small-Cap Pharmaceuticals
Oct 12th, 2006 | By James Boric | Category: Technology
The last time a pharmaceutical company showed up on my insider-buying screen it rose 700% in less than a year.
Back in May 2005, company insiders at ViroPharma (VPHM:NASDAQ) bought 233,500 shares of their own stock. They were obviously banking that their novel drug, Vanocin (which treated acne and various skin ...read more
